Like_老虎社区_美港股上老虎

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":699989919,"tweetId":"699989919","gmtCreate":1639735242820,"gmtModify":1639735423977,"author":{"id":3579028995240368,"idStr":"3579028995240368","authorId":3579028995240368,"authorIdStr":"3579028995240368","name":"Jfierydragon","avatar":"https://static.tigerbbs.com/32ea74904661b2d0a43f0cc648caae68","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":9,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Like</body></html>","htmlText":"<html><head></head><body>Like</body></html>","text":"Like","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/699989919","repostId":1132933677,"repostType":4,"repost":{"id":"1132933677","kind":"news","pubTimestamp":1639735046,"share":"https://www.laohu8.com/m/news/1132933677?lang=&edition=full","pubTime":"2021-12-17 17:57","market":"us","language":"en","title":"58 Biggest Movers From Yesterday","url":"https://stock-news.laohu8.com/highlight/detail?id=1132933677","media":"Benzinga","summary":"Gainers\n\nAdagio Therapeutics, Inc. shares jumped 123.3% to settle at $14.18 on Thursday after trader","content":"Gainers\n<ul>\n <li>Adagio Therapeutics, Inc.&nbsp;shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.</li>\n <li>Kaixin Auto Holdings&nbsp;surged 36.3% to close at $1.69 after the company announced an agreement with Bujia, which agreed to order at least 10,000 new energy trucks from Kaixin in the next five years.</li>\n <li>Assertio Holdings, Inc.&nbsp;surged 23.7% to close at $1.67 after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.</li>\n <li>Aptose Biosciences Inc.&nbsp;gained 23.5% to settle at $1.47. Aptose Biosciences recently reported HM43239 data featured in an oral presentation at the ASH Annual Meeting.</li>\n <li>Calliditas Therapeutics AB&nbsp;shares jumped 22.3% to close at $22.93 on Thursday after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.</li>\n <li>Arcturus Therapeutics Holdings Inc.&nbsp;surged 21.1% to close at $43.00 after reporting new data and providing additional updates from ARCT-154 and ARCT-165 clinical trials.</li>\n <li>Zai Lab Limited&nbsp;climbed 20.7% to close at $66.26 after the company announced China has approved NUZYRA as a category 1 innovative drug for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.</li>\n <li>Datasea Inc.&nbsp;gained 20.3% to settle at $1.54.</li>\n <li>X4 Pharmaceuticals, Inc.&nbsp;rose 17.3% to close at $2.37. X4 Pharmaceuticals recently presented new clinical and scientific data at the 2021 ASH Annual Meeting.</li>\n <li>Splash Beverage Group, Inc.&nbsp;gained 17.3% to settle at $1.22. Splash Beverage Group recently engaged TraDigital IR as its digital communication provider.</li>\n <li>Mechel PAO&nbsp;jumped 16.9% to close at $3.11.</li>\n <li>Nexters Inc.&nbsp;gained 16.7% to settle at $8.75.</li>\n <li>Purple Innovation, Inc.&nbsp;jumped 16.6% to close at $10.90. Purple Innovation recently said it anticipates FY21 net sales and adjusted EBITDA at the low end of the prior guidance ranges.</li>\n <li>New Found Gold Corp.&nbsp;rose 15.9% to settle at $6.21.</li>\n <li>Valneva SE&nbsp;gained 15.6% to close at $58.95 after the company announced results from the homologous booster data in the Phase 1/2 study confirm that VLA2001 significantly boosted immunity in participants who received VLA2001 as a primary vaccination.</li>\n <li>Cabaletta Bio, Inc.&nbsp;surged 15.4% to settle at $4.58. Cabaletta Bio recently said its DSG3-CAART failed to show biologic activity to date in the two lowest cell dose cohorts of Phase 1 trial mucosal Pemphigus Vulgaris (mPV).</li>\n <li>Euro Tech Holdings Company Limited&nbsp;gained 15.4% to close at $3.38.</li>\n <li>Alpha Pro Tech, Ltd.&nbsp;gained 14.6% to settle at $6.13. Alpha Pro Tech recently added $2 million to its buyback program.</li>\n <li>Cadiz Inc.&nbsp;jumped 13.6% to close at $4.26.</li>\n <li>CooTek (Cayman) Inc.&nbsp;climbed 11.8% to close at $0.54 after dropping more than 10% on Wednesday.</li>\n <li>Stryve Foods, Inc.&nbsp;gained 11.3% to close at $3.74 following news of deals for the expansion of its domestic US distribution and product line penetration with Costco and Walmart.</li>\n <li>Doma Holdings Inc.&nbsp;jumped 10.1% to settle at $5.43.</li>\n <li>American Virtual Cloud Technologies, Inc.&nbsp;gained 9.8% to close at $1.68 after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.</li>\n <li>Engine Gaming and Media, Inc.&nbsp;rose 8.4% to close at $3.10.</li>\n <li>Jowell Global Ltd.&nbsp;rose 8.1% to close at $19.10. Jowell Global recently posted Q3 sales of $43.80 million.</li>\n <li>MoneyLion Inc.&nbsp;rose 7.8% to settle at $3.73 as the company announced plans to acquire Even Financial for up to $440 million.</li>\n <li>Petros Pharmaceuticals, Inc.&nbsp;gained 7.3% to close at $3.08 after gaining over 4% on Wednesday.</li>\n <li>HUTCHMED (China) Limited&nbsp;gained 6.3% to close at $33.92.</li>\n <li>Retail Value Inc.&nbsp;rose 4.6% to close at $6.34 after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.</li>\n</ul>\nLosers\n<ul>\n <li>Bakkt Holdings, Inc.&nbsp;shares dipped 34% to settle at $9.08 on Thursday after the company reported a mixed shelf offering.</li>\n <li>IronNet, Inc.&nbsp;shares fell 31.5% to close at $4.66 on Thursday after the company said Q3 sales results were lower year over year. Needham downgraded IronNet from Buy to Hold.</li>\n <li>uniQure N.V.&nbsp;fell 29.6% to close at $20.24 after the company reported clinical update on first patients in Phase I/II clinical trial of AMT-130 gene therapy for the treatment of Huntington's disease.</li>\n <li>Aerovate Therapeutics, Inc.&nbsp;dropped 25.9% to settle at $9.14. Aerovate Therapeutics recently announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.</li>\n <li>P3 Health Partners Inc.&nbsp;fell 21.5% to settle at $8.74.</li>\n <li>Theseus Pharmaceuticals, Inc.&nbsp;declined 21% to close at $9.94.</li>\n <li>Ensysce Biosciences, Inc.&nbsp;fell 20.4% to close at $3.27. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.</li>\n <li>Danimer Scientific, Inc.&nbsp;shares declined 20.1% to close at $8.46 after the company reported a proposed convertible senior notes offering.</li>\n <li>East Stone Acquisition Corporation&nbsp;declined 19.8% to settle at $12.22.</li>\n <li>Bird Global, Inc.&nbsp;fell 19.2% to close at $7.25.</li>\n <li>Terawulf Inc.&nbsp;dropped 16.9% to settle at $16.23. TeraWulf recently said it has completed previously-announced business combo deal with IKONICS.</li>\n <li>InnSuites Hospitality Trust&nbsp;declined 16.2% to close at $2.27.</li>\n <li>Quoin Pharmaceuticals, Ltd.&nbsp;fell 13.7% to close at $2.40. Quoin Pharma recently announced an exclusive distribution agreement with Orpharm LLC for QRX003.</li>\n <li>Regional Health Properties, Inc.&nbsp;fell 19.7% to settle at $5.38. Regional Health Props, last month, posted Q3 loss of $1.25 per share.</li>\n <li>MiNK Therapeutics, Inc.&nbsp;dropped 18.7% to close at $4.39.</li>\n <li>Agrify Corporation&nbsp;fell 17.8% to close at $10.34.</li>\n <li>Flexsteel Industries, Inc.&nbsp;dropped 16.5% to settle at $24.68. Flexsteel Industries raised its Q2 sales guidance from 130 million-$140 million to $137 million -$143 million.</li>\n <li>Xilio Therapeutics, Inc.&nbsp;fell 15% to settle at $9.89.</li>\n <li>Muscle Maker, Inc.&nbsp;fell 14.9% to close at $0.8932.</li>\n <li>Ambarella, Inc.&nbsp;declined 14.3% to close at $179.63.</li>\n <li>Entrada Therapeutics, Inc.&nbsp;fell 14.2% to settle at $15.35 after the company reported Q3 EPS were lower year over year.</li>\n <li>Endo International plc&nbsp;declined 14.1% to close at $3.71 after Barclays lowered its price target from $7 to $5.</li>\n <li>Volcon, Inc.&nbsp;shares dropped 13.9% to settle at $8.74. Volcon recently announced dealership agreement with Nash Powersports.</li>\n <li>Sprout Social, Inc.&nbsp;shares declined 13.9% to close at $82.04 after Morgan Stanley lowered its price target on the stock from $146 to $110.</li>\n <li>IsoPlexis Corporation&nbsp;fell 13.9% to close at $6.02.</li>\n <li>Unity Biotechnology, Inc.&nbsp;dipped 12.5% to settle at $1.54.</li>\n <li>Doximity, Inc.&nbsp;fell 11.5% to settle at $49.32.</li>\n <li>Adobe Inc.&nbsp;dropped 10.2% to close at $566.09 after the company issued Q1 and FY22 EPS and sales guidance below analyst estimates.</li>\n <li>C3.ai, Inc.&nbsp;fell 9.9% to close at $31.54 after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $45 to $31.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>58 Biggest Movers From Yesterday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n58 Biggest Movers From Yesterday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 17:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24664507/58-biggest-movers-from-yesterday>Benzinga</a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\nGainers\n\nAdagio Therapeutics, Inc. shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.\nKaixin Auto ...\n\n<a href=\"https://www.benzinga.com/news/21/12/24664507/58-biggest-movers-from-yesterday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals Inc","ADBE":"Adobe","KXIN":"开心汽车"},"source_url":"https://www.benzinga.com/news/21/12/24664507/58-biggest-movers-from-yesterday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132933677","content_text":"Gainers\n\nAdagio Therapeutics, Inc. shares jumped 123.3% to settle at $14.18 on Thursday after traders circulated rumors of a reiterated Buy rating and $46 price target from Jefferies.\nKaixin Auto Holdings surged 36.3% to close at $1.69 after the company announced an agreement with Bujia, which agreed to order at least 10,000 new energy trucks from Kaixin in the next five years.\nAssertio Holdings, Inc. surged 23.7% to close at $1.67 after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nAptose Biosciences Inc. gained 23.5% to settle at $1.47. Aptose Biosciences recently reported HM43239 data featured in an oral presentation at the ASH Annual Meeting.\nCalliditas Therapeutics AB shares jumped 22.3% to close at $22.93 on Thursday after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nArcturus Therapeutics Holdings Inc. surged 21.1% to close at $43.00 after reporting new data and providing additional updates from ARCT-154 and ARCT-165 clinical trials.\nZai Lab Limited climbed 20.7% to close at $66.26 after the company announced China has approved NUZYRA as a category 1 innovative drug for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.\nDatasea Inc. gained 20.3% to settle at $1.54.\nX4 Pharmaceuticals, Inc. rose 17.3% to close at $2.37. X4 Pharmaceuticals recently presented new clinical and scientific data at the 2021 ASH Annual Meeting.\nSplash Beverage Group, Inc. gained 17.3% to settle at $1.22. Splash Beverage Group recently engaged TraDigital IR as its digital communication provider.\nMechel PAO jumped 16.9% to close at $3.11.\nNexters Inc. gained 16.7% to settle at $8.75.\nPurple Innovation, Inc. jumped 16.6% to close at $10.90. Purple Innovation recently said it anticipates FY21 net sales and adjusted EBITDA at the low end of the prior guidance ranges.\nNew Found Gold Corp. rose 15.9% to settle at $6.21.\nValneva SE gained 15.6% to close at $58.95 after the company announced results from the homologous booster data in the Phase 1/2 study confirm that VLA2001 significantly boosted immunity in participants who received VLA2001 as a primary vaccination.\nCabaletta Bio, Inc. surged 15.4% to settle at $4.58. Cabaletta Bio recently said its DSG3-CAART failed to show biologic activity to date in the two lowest cell dose cohorts of Phase 1 trial mucosal Pemphigus Vulgaris (mPV).\nEuro Tech Holdings Company Limited gained 15.4% to close at $3.38.\nAlpha Pro Tech, Ltd. gained 14.6% to settle at $6.13. Alpha Pro Tech recently added $2 million to its buyback program.\nCadiz Inc. jumped 13.6% to close at $4.26.\nCooTek (Cayman) Inc. climbed 11.8% to close at $0.54 after dropping more than 10% on Wednesday.\nStryve Foods, Inc. gained 11.3% to close at $3.74 following news of deals for the expansion of its domestic US distribution and product line penetration with Costco and Walmart.\nDoma Holdings Inc. jumped 10.1% to settle at $5.43.\nAmerican Virtual Cloud Technologies, Inc. gained 9.8% to close at $1.68 after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nEngine Gaming and Media, Inc. rose 8.4% to close at $3.10.\nJowell Global Ltd. rose 8.1% to close at $19.10. Jowell Global recently posted Q3 sales of $43.80 million.\nMoneyLion Inc. rose 7.8% to settle at $3.73 as the company announced plans to acquire Even Financial for up to $440 million.\nPetros Pharmaceuticals, Inc. gained 7.3% to close at $3.08 after gaining over 4% on Wednesday.\nHUTCHMED (China) Limited gained 6.3% to close at $33.92.\nRetail Value Inc. rose 4.6% to close at $6.34 after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\n\nLosers\n\nBakkt Holdings, Inc. shares dipped 34% to settle at $9.08 on Thursday after the company reported a mixed shelf offering.\nIronNet, Inc. shares fell 31.5% to close at $4.66 on Thursday after the company said Q3 sales results were lower year over year. Needham downgraded IronNet from Buy to Hold.\nuniQure N.V. fell 29.6% to close at $20.24 after the company reported clinical update on first patients in Phase I/II clinical trial of AMT-130 gene therapy for the treatment of Huntington's disease.\nAerovate Therapeutics, Inc. dropped 25.9% to settle at $9.14. Aerovate Therapeutics recently announced the initiation of its IMPAHCT Phase 2b/Phase 3 trial of AV-101 In Pulmonary Arterial Hypertension.\nP3 Health Partners Inc. fell 21.5% to settle at $8.74.\nTheseus Pharmaceuticals, Inc. declined 21% to close at $9.94.\nEnsysce Biosciences, Inc. fell 20.4% to close at $3.27. Ensysce Biosciences said that the first patients have been enrolled in Phase 1 study of PF614-MPAR, its unique technology platform to provide opioid overdose protection.\nDanimer Scientific, Inc. shares declined 20.1% to close at $8.46 after the company reported a proposed convertible senior notes offering.\nEast Stone Acquisition Corporation declined 19.8% to settle at $12.22.\nBird Global, Inc. fell 19.2% to close at $7.25.\nTerawulf Inc. dropped 16.9% to settle at $16.23. TeraWulf recently said it has completed previously-announced business combo deal with IKONICS.\nInnSuites Hospitality Trust declined 16.2% to close at $2.27.\nQuoin Pharmaceuticals, Ltd. fell 13.7% to close at $2.40. Quoin Pharma recently announced an exclusive distribution agreement with Orpharm LLC for QRX003.\nRegional Health Properties, Inc. fell 19.7% to settle at $5.38. Regional Health Props, last month, posted Q3 loss of $1.25 per share.\nMiNK Therapeutics, Inc. dropped 18.7% to close at $4.39.\nAgrify Corporation fell 17.8% to close at $10.34.\nFlexsteel Industries, Inc. dropped 16.5% to settle at $24.68. Flexsteel Industries raised its Q2 sales guidance from 130 million-$140 million to $137 million -$143 million.\nXilio Therapeutics, Inc. fell 15% to settle at $9.89.\nMuscle Maker, Inc. fell 14.9% to close at $0.8932.\nAmbarella, Inc. declined 14.3% to close at $179.63.\nEntrada Therapeutics, Inc. fell 14.2% to settle at $15.35 after the company reported Q3 EPS were lower year over year.\nEndo International plc declined 14.1% to close at $3.71 after Barclays lowered its price target from $7 to $5.\nVolcon, Inc. shares dropped 13.9% to settle at $8.74. Volcon recently announced dealership agreement with Nash Powersports.\nSprout Social, Inc. shares declined 13.9% to close at $82.04 after Morgan Stanley lowered its price target on the stock from $146 to $110.\nIsoPlexis Corporation fell 13.9% to close at $6.02.\nUnity Biotechnology, Inc. dipped 12.5% to settle at $1.54.\nDoximity, Inc. fell 11.5% to settle at $49.32.\nAdobe Inc. dropped 10.2% to close at $566.09 after the company issued Q1 and FY22 EPS and sales guidance below analyst estimates.\nC3.ai, Inc. fell 9.9% to close at $31.54 after Morgan Stanley maintained an Underweight rating on the stock and lowered its price target from $45 to $31.","news_type":1},"isVote":1,"tweetType":1,"viewCount":873,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":4,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/699989919"}